Get started
Author

Sara Beiggi

Observed name: S Beiggi
OpenAlex ID: A5025517375
On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2014 · Iris Gehrke, Eric D.J. Bouchard, et al. · Clinical Cancer Research · 80
Evolution of ITS Ribosomal RNA Secondary Structures in Fungal and Algal Symbionts of Selected Species of Cladonia sect. Cladonia (Cladoniaceae, Ascomycotina)
2007 · Sara Beiggi, Michele D. Piercey-Normore · Journal of Molecular Evolution · 44
Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study
2013 · S Beiggi, J B Johnston, et al. · British Journal of Cancer · 41
PDF
Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival
2019 · Ganchimeg Ishdorj, Sara Beiggi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 38
Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia
2015 · Jitra Kriangkum, Sarah N. Motz, et al. · PLoS ONE · 30
PDF
Comparison of outcome of patients with CLL who are referred or nonreferred to a specialized CLL clinic: a Canadian population‐based study
2016 · Sara Beiggi, Versha Banerji, et al. · Cancer Medicine · 13
PDF
A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia
2017 · Ganchimeg Ishdorj, Sara E.F. Kost, et al. · Leukemia Research · 5
Buccal cell telomere length is not a useful marker for comorbidities in chronic lymphocytic leukemia
2019 · Lin Yang, Sara E.F. Kost, et al. · Leukemia Research · 2
Incidence and Implications of Skin Cancers in Cancercare Manitoba Chronic Lymphocytic Leukemia (CLL) Clinic Patients
2016 · Sara Beiggi, Mohammad Pannu, et al. · Blood · 2
High Cumulative Illness Rating Scale (CIRS) Score in CLL Correlates with Short CLL Telomere Length and Decreased Survival
2016 · Lin Yang, Sara Beiggi, et al. · Blood · 1
Supplemental Table S2 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Figure S2 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Table S1 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Figure S1 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Figure Legend from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Figure S3 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Data from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Data from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Figure S2 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Figure S3 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Table S1 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Figure S1 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Figure Legend from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Supplemental Table S2 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
2023 · Iris Gehrke, Eric D.J. Bouchard, et al.
Revelance of Gammaglobulin Levels at Diagnosis and during Disease Course in Chronic Lymphocytic Leukemia
2016 · Erin Streu, Jayce Bi, et al. · Blood
Works count: 33
Citation count: 256
H-index: 6
I10-index: 6
Year
Topic
Type